Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/deconstructing-clinical-trials-help-from-oncology-value-frameworks-022boRR0qd
References (9)
-
A. Chandra, J. Shafrin, R. Dhawan (2016)
Utility of Cancer Value Frameworks for Patients, Payers, and Physicians.JAMA, 315 19
-
J. Paggio, R. Sullivan, R. Sullivan, D. Schrag, W. Hopman, B. Azariah, C. Pramesh, I. Tannock, I. Tannock, C. Booth (2017)
Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks.The Lancet. Oncology, 18 7
-
S. Mailankody, V. Prasad (2015)
Five Years of Cancer Drug Approvals: Innovation, Efficacy, and Costs.JAMA oncology, 1 4
-
F. Vera-Badillo, Marc Napoleone, M. Krzyzanowska, S. Alibhai, A. Chan, A. Ocaña, B. Seruga, A. Templeton, E. Amir, I. Tannock (2016)
Bias in reporting of randomised clinical trials in oncology.European journal of cancer, 61
-
J. Paggio, B. Azariah, R. Sullivan, W. Hopman, F. James, S. Roshni, I. Tannock, C. Booth (2016)
Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?Annals of Oncology, 28
-
S. Berry, C. Bell, P. Ubel, W. Evans, E. Nadler, E. Strevel, P. Neumann (2010)
Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 27
-
M. Hellmann, M. Kris, C. Rudin (2016)
Medians and Milestones in Describing the Path to Cancer Cures: Telling "Tails".JAMA oncology, 2 2
-
I. Tannock, E. Amir, C. Booth, S. Niraula, A. Ocaña, B. Seruga, A. Templeton, F. Vera-Badillo (2016)
Relevance of randomised controlled trials in oncology.The Lancet. Oncology, 17 12
-
C. Booth, E. Eisenhauer (2012)
Progression-free survival: meaningful or simply measurable?Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30 10
- Publisher
- American Medical Association
- Copyright
- Copyright 2017 American Medical Association. All Rights Reserved.
- ISSN
- 2374-2437
- eISSN
- 2374-2445
- DOI
- 10.1001/jamaoncol.2017.1312
- Publisher site
- See Article on Publisher Site
Abstract
This Viewpoint discusses the importance of oncology value frameworks as tools for oncologists in training.
Journal
JAMA Oncology – American Medical Association
Published: Oct 1, 2017